Related Experiment Video
Updated: Jul 18, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
COVID-19-Induced Cardiac Tamponade: A Case Study and a Literature Review
Rishabh Mishra1, Swati Jain2, Mohammed Shaban3
1Hospital Medicine, Montefiore Medical Center, Wakefield Campus, Bronx, USA.
This case study highlights a COVID-19 patient who developed cardiac tamponade. Early diagnosis and conservative treatment of this viral-induced heart complication are crucial for recovery.
Area of Science:
- Cardiology
- Infectious Diseases
Background:
- COVID-19 presents heterogeneously, with potential cardiac complications.
- Viral illnesses, including SARS-CoV-2, can precipitate pericardial effusion and cardiac tamponade.
Observation:
- A 79-year-old female with COVID-19 presented with dyspnea and cough.
- Imaging revealed a bottle-shaped heart, pericardial effusion, and echocardiographic signs of tamponade.
Findings:
- The patient was diagnosed with moderate pericardial effusion and cardiac tamponade secondary to SARS-CoV-2 infection.
- Conservative management including colchicine, ibuprofen, and dexamethasone led to improvement.
Implications:
- Prompt recognition and management of COVID-19-induced cardiac tamponade are essential.
- Early, targeted therapy can prevent complications and avoid invasive procedures.
Related Concept Videos
Pericarditis IV: Nursing Management
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

